SELECT LANGUAGE BELOW

New mpox strain confirmed in NY for the first time

The New York State Department of Health issued a health advisor on Wednesday regarding the emergence of new strains of MPOX (formerly Monkeypox).

The first case of MPOX clade IB in New York was confirmed in a symptomatic individual who recently traveled from Africa.

The current risk to the public remains low, the department says, and there are currently no known known cases of the strain community in New York.

State Health Director Dr. James McDonald shared that the infected individual was caring for a doctor and was isolated “up to the full resolution of symptoms.”

“There are no known local MPOX clade IB transmissions in communities where individuals live within New York,” he said in a statement.

McDonald's added that the Jynneos vaccine, a two-dose preventative vaccine series for MPOX, is “expected to be effective” against the new strain.

“[It is] It is available to individuals at risk in the permanent order that they signed last year,” he pointed out. “There's no immediate risk to the public.”

The Health Department added in advice that individuals should contact their local pharmacies or healthcare providers regarding availability of vaccines when individuals “continue to monitor and maintain the situation.”

The New York State Department of Health has issued a health recommendation on new strains of MPOX (formerly Monkeypox). AP

MPOX is “rarely fatal,” according to the department, but can be dangerous for people with immunocompromised conditions, elderly people, young children and pregnant women.

Symptoms include swollen lymph nodes, fever, sore throat, lower back pain, low energy and muscle pain, as well as rashes that progress to “painful skin lesions.”

There is a “high probability of transmission” until these lesions become faintly faint. In other words, infected individuals are encouraged to isolate until new skin forms at the lesion site.

Symptoms may include rashes that progress to “painful skin lesions.” Getty Images
The first case of a new MPOX strain was confirmed in New York.
AP

MPOX can spread through intimate contact with pain, scabs, or rash, and the department can spread through the breathing fluid, saliva, or mucus of an infected person.

Experts recommend that those planning to travel to areas with reported cases of MPOX should consider getting vaccinated with two doses of Jynneos.

Dr. Miles Druckman, global medical director of International SOS in California, told Fox News Digital that the stock has been reported in several countries in central and eastern Africa.

“Other countries have also reported cases related to Clade I travel, including Belgium, Canada, China, France, Germany, India, Ireland, Oman, Pakistan, South Sudan, Sweden, Thailand, the United Kingdom and Zimbabwe. I know that, he pointed out.

“It is important to recognize that cases of this strain are expected due to the ongoing outbreaks in multiple countries and risks associated with global travel.”

MPOX can be infected for up to four days before symptoms develop, but according to Druckman, it is the most contagious as symptoms appear until about 2-4 weeks later.

Experts emphasized that vaccinations are recommended for high-risk individuals, such as healthcare workers with high exposure and those with weakened immune systems.

“MPOX prevention primarily avoids vaccination and skin-skin contact with others, especially those with symptoms or visible development, observes good personal hygiene and frequent washing of hands. ” he added.

Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp

Related News